165 related articles for article (PubMed ID: 12019147)
1. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.
Kim JS; Crooks H; Dracheva T; Nishanian TG; Singh B; Jen J; Waldman T
Cancer Res; 2002 May; 62(10):2744-8. PubMed ID: 12019147
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen RH; McCormick F
Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin as oncogene: the smoking gun.
Peifer M
Science; 1997 Mar; 275(5307):1752-3. PubMed ID: 9122680
[No Abstract] [Full Text] [Related]
5. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
6. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
Wakita K; Tetsu O; McCormick F
Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
[TBL] [Abstract][Full Text] [Related]
7. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
8. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
[TBL] [Abstract][Full Text] [Related]
9. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
[TBL] [Abstract][Full Text] [Related]
10. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
11. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin.
Fujita M; Furukawa Y; Nagasawa Y; Ogawa M; Nakamura Y
Cancer Res; 2000 Dec; 60(23):6683-7. PubMed ID: 11118053
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells.
Ikenoue T; Ijichi H; Kato N; Kanai F; Masaki T; Rengifo W; Okamoto M; Matsumura M; Kawabe T; Shiratori Y; Omata M
Jpn J Cancer Res; 2002 Nov; 93(11):1213-20. PubMed ID: 12460462
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
15. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
Furlong MT; Morin PJ
Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
[TBL] [Abstract][Full Text] [Related]
16. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]